ADAMTS-13 FRET Substrate

<strong>ADAMTS-13 FRET Substrate</strong>_x000D_ <strong>Catalog number:</strong> B2011287_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 8314.9 g/mol_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> FRETS-VWF73_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Levi M, Scully M, Singer M. The role of ADAMTS-13 in the coagulopathy of sepsis J Thromb Haemost. 2018 Apr;16(4):646-651._x000D_ 2: Boender J, Nederlof A, Meijer K, Mauser-Bunschoten EP, Cnossen MH, Fijnvandraat K, van der Bom JG, de Meris J, Laros-van Gorkom BAP, van Galen KPM, Eikenboom J, de Maat MPM, Leebeek FWG; WiN Study Group. ADAMTS-13 and bleeding phenotype in von Willebrand disease Res Pract Thromb Haemost. 2020 Oct 31;4(8):1331-1339._x000D_ 3: South K, Lane DA. ADAMTS-13 and von Willebrand factor: a dynamic duo J Thromb Haemost. 2018 Jan;16(1):6-18._x000D_ 4: Veyradier A, Girma JP. Assays of ADAMTS-13 activity Semin Hematol. 2004 Jan;41(1):41-7._x000D_ 5: South K, Freitas MO, Lane DA. Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity J Thromb Haemost. 2016 Oct;14(10):2011-2022._x000D_ 6: Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura Semin Thromb Hemost. 2010 Feb;36(1):71-81._x000D_ 7: Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, Hamdan A, Antun AG, Metjian A, Sadler JE; ART Investigators. Adjuvant low-dose rituximab and plasma exchange for acquired TTP Blood. 2019 Sep 26;134(13):1106-1109._x000D_ 8: Halkidis K, Siegel DL, Zheng XL. A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura J Thromb Haemost. 2021 Aug;19(8):1888-1895._x000D_ 9: Pekcan MK, Sarıkaya E, Tokmak A, Alışık M, Alkan A, Özakşit G, Erel Ö. ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion Kaohsiung J Med Sci. 2017 Jan;33(1):30-35._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/16102032">10: Lämmle B, Kremer Hovinga JA, Alberio L. Thrombotic thrombocytopenic purpura J Thromb Haemost. 2005 Aug;3(8):1663-75. </a>_x000D_ _x000D_ <strong>Products Related to ADAMTS-13 FRET Substrate can be found at</strong> <a href="https://moleculardepot.com/product-category/Substrates/"> Substrates</a>